HLA-G expression in hematologic malignancies (Q37810072)

23 August 2017

title

HLA-G expression in hematologic malignancies (English)

1 reference

23 August 2017

Wei-Hua Yan

1

1 reference

23 August 2017

publication date

1 February 2010

1 reference

Expert Review of Hematology

23 August 2017

published in

1 reference

23 August 2017

volume

3

1 reference

23 August 2017

issue

1

1 reference

23 August 2017

page(s)

67-80

1 reference

Cancer immunoediting: from immunosurveillance to tumor escape

23 August 2017

cites work

1 reference

Non-classical major histocompatibility complex proteins as determinants of tumour immunosurveillance.

21 January 2018

1 reference

Non-classical HLA-G antigen and its role in the cancer progression

21 January 2018

1 reference

HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism?

21 January 2018

1 reference

HLA-G-dependent suppressor cells: Diverse by nature, function, and significance.

21 January 2018

1 reference

HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance

21 January 2018

1 reference

Secretion of sHLA-G molecules in malignancies

21 January 2018

1 reference

Human leukocyte antigen-G protein expression is an unfavorable prognostic predictor of hepatocellular carcinoma following curative resection

21 January 2018

1 reference

Expression of tolerogenic HLA-G molecules in cancer prevents antitumor responses.

21 January 2018

1 reference

Human leukocyte antigen-G and cancer immunoediting

21 January 2018

1 reference

The regulation of HLA class I expression: is HLA-G the odd one out?

21 January 2018

1 reference

Unfavourable clinical implications for HLA-G expression in acute myeloid leukaemia

21 January 2018

1 reference

Soluble HLA-G molecules increase during acute leukemia, especially in subtypes affecting monocytic and lymphoid lineages

21 January 2018

1 reference

NK resistance of tumor cells from multiple myeloma and chronic lymphocytic leukemia patients: implication of HLA-G.

21 January 2018

1 reference

Beyond the increasing complexity of the immunomodulatory HLA-G molecule

21 January 2018

1 reference

A human major histocompatibility complex class I gene that encodes a protein with a shortened cytoplasmic segment

21 January 2018

1 reference

HLA-G molecules: from maternal-fetal tolerance to tissue acceptance

21 January 2018

1 reference

Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells.

21 January 2018

1 reference

Detection of HLA-G5 secreting cells.

21 January 2018

1 reference

Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens

21 January 2018

1 reference

A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells

21 January 2018

1 reference

A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells

21 January 2018

1 reference

The biology of human natural killer-cell subsets

21 January 2018

1 reference

Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G

21 January 2018

1 reference

Residues Met76 and Gln79 in HLA-G alpha1 domain involve in KIR2DL4 recognition

21 January 2018

1 reference

Soluble HLA-G: Are they clinically relevant?

21 January 2018

1 reference

Activation of NK cells by an endocytosed receptor for soluble HLA-G.

21 January 2018

1 reference

Soluble HLA-G molecules impair natural killer/dendritic cell crosstalk via inhibition of dendritic cells.

21 January 2018

1 reference

Human leukocyte antigen-G expression after heart transplantation is associated with a reduced incidence of rejection

21 January 2018

1 reference

Erythroblasts secrete the nonclassical HLA-G molecule from primitive to definitive hematopoiesis.

21 January 2018

1 reference

HLA-G turns off erythropoietin receptor signaling through JAK2 and JAK2 V617F dephosphorylation: clinical relevance in polycythemia vera.

21 January 2018

1 reference

HLA-G: from biology to clinical benefits

21 January 2018

1 reference

Expression of HLA-G in inflammatory bowel disease provides a potential way to distinguish between ulcerative colitis and Crohn's disease.

21 January 2018

1 reference

Analysis of HLA-G expression in malignant hematopoetic cells from leukemia patients.

21 January 2018

1 reference

Activation of HLA-G expression by 5-aza-2 - deoxycytidine in malignant hematopoetic cells isolated from leukemia patients

21 January 2018

1 reference

HLA-G class I gene expression in normal and malignant hematopoietic cells

21 January 2018

1 reference

HLA-G and lymphoproliferative disorders

21 January 2018

1 reference

HLA-G expression in B chronic lymphocytic leukemia: a new prognostic marker?

21 January 2018

1 reference

HLA-G protein processing and transport to the cell surface

21 January 2018

1 reference

The short forms of HLA-G are unlikely to play a role in pregnancy because they are not expressed at the cell surface

21 January 2018

1 reference

HLA-G in human reproduction: aspects of genetics, function and pregnancy complications

21 January 2018

1 reference

HLA-G and inflammatory diseases

21 January 2018

1 reference

Soluble HLA-G and embryo implantation: frequently asked questions.

21 January 2018

1 reference

Secretion of pro-apoptotic intron 4-retaining soluble HLA-G1 by human villous trophoblast.

21 January 2018

1 reference

Detection of soluble HLA-G molecules in plasma and amniotic fluid

21 January 2018

1 reference

Expression of functional soluble human leucocyte antigen-G molecules in lymphoproliferative disorders.

21 January 2018

1 reference

Serum level of soluble human leukocyte antigen-G molecules in non-Hodgkin lymphoma: does it have a prognostic value?

21 January 2018

1 reference

HLA-G in melanoma: can the current controversies be solved?

21 January 2018

1 reference

Transcriptional regulation of the MHC class Ib genes HLA-E, HLA-F, and HLA-G.

21 January 2018

1 reference

HLA-G and IL-10 expression in human cancer--different stories with the same message

21 January 2018

1 reference

HLA-G gene repression is reversed by demethylation

21 January 2018

1 reference

Cause and consequences of genetic and epigenetic alterations in human cancer.

21 January 2018

1 reference

Epigenetics in cancer: targeting chromatin modifications

21 January 2018

1 reference

Demethylating agent 5-aza-2'-deoxycytidine activates HLA-G expression in human leukemia cell lines

21 January 2018

1 reference

Induction of HLA-G expression in a melanoma cell line OCM-1A following the treatment with 5-aza-2'-deoxycytidine

21 January 2018

1 reference

Epigenetic modifiers: basic understanding and clinical development.

21 January 2018

1 reference

Functional up-regulation of human leukocyte antigen class I antigens expression by 5-aza-2'-deoxycytidine in cutaneous melanoma: immunotherapeutic implications.

21 January 2018

1 reference

HLA-G 14-bp polymorphism regulates the methotrexate response in rheumatoid arthritis.

21 January 2018

1 reference

Hypoxia modulates HLA-G gene expression in tumor cells.

21 January 2018

1 reference

Progesterone enhances HLA-G gene expression in JEG-3 choriocarcinoma cells and human cytotrophoblasts in vitro

21 January 2018

1 reference

Progesterone regulates HLA-G gene expression through a novel progesterone response element

21 January 2018

1 reference

Progesterone induces human leukocyte antigen-g expression in vascular endothelial and smooth muscle cells

21 January 2018

1 reference

Extracellular ATP acting at the P2X7 receptor inhibits secretion of soluble HLA-G from human monocytes.

21 January 2018

1 reference

Allele-specific targeting of microRNAs to HLA-G and risk of asthma

21 January 2018

1 reference

HLA-G protein expression as a potential immune escape mechanism in classical Hodgkin’s lymphoma

21 January 2018

1 reference

A Specific Interferon (IFN)-stimulated Response Element of the Distal HLA-G Promoter Binds IFN-regulatory Factor 1 and Mediates Enhancement of This Nonclassical Class I Gene by IFN-β

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/EHM.09.72

1 reference

23 August 2017

1 reference